264 related articles for article (PubMed ID: 28674905)
1. Plasma Biomarker Identification and Quantification by Microparticle Proteomics.
Harel M; Geiger T
Methods Mol Biol; 2017; 1619():477-486. PubMed ID: 28674905
[TBL] [Abstract][Full Text] [Related]
2. Proteomics of microparticles with SILAC Quantification (PROMIS-Quan): a novel proteomic method for plasma biomarker quantification.
Harel M; Oren-Giladi P; Kaidar-Person O; Shaked Y; Geiger T
Mol Cell Proteomics; 2015 Apr; 14(4):1127-36. PubMed ID: 25624350
[TBL] [Abstract][Full Text] [Related]
3. Protein Biomarker Discovery Using Human Blood Plasma Microparticles.
Taleb RSZ; Moez P; Younan D; Eisenacher M; Tenbusch M; Sitek B; Bracht T
Methods Mol Biol; 2019; 1959():51-64. PubMed ID: 30852815
[TBL] [Abstract][Full Text] [Related]
4. Rapid Isolation of Extracellular Vesicles from Blood Plasma with Size-Exclusion Chromatography Followed by Mass Spectrometry-Based Proteomic Profiling.
Kreimer S; Ivanov AR
Methods Mol Biol; 2017; 1660():295-302. PubMed ID: 28828666
[TBL] [Abstract][Full Text] [Related]
5. Best practice of identification and proteomic analysis of extracellular vesicles in human health and disease.
Sódar BW; Kovács Á; Visnovitz T; Pállinger É; Vékey K; Pocsfalvi G; Turiák L; Buzás EI
Expert Rev Proteomics; 2017 Dec; 14(12):1073-1090. PubMed ID: 29025360
[TBL] [Abstract][Full Text] [Related]
6. Systematic evaluation of label-free and super-SILAC quantification for proteome expression analysis.
Tebbe A; Klammer M; Sighart S; Schaab C; Daub H
Rapid Commun Mass Spectrom; 2015 May; 29(9):795-801. PubMed ID: 26377007
[TBL] [Abstract][Full Text] [Related]
7. Differential ultracentrifugation enables deep plasma proteomics through enrichment of extracellular vesicles.
Kverneland AH; Østergaard O; Emdal KB; Svane IM; Olsen JV
Proteomics; 2023 Apr; 23(7-8):e2200039. PubMed ID: 36398564
[TBL] [Abstract][Full Text] [Related]
8. Phosphoproteins in extracellular vesicles as candidate markers for breast cancer.
Chen IH; Xue L; Hsu CC; Paez JS; Pan L; Andaluz H; Wendt MK; Iliuk AB; Zhu JK; Tao WA
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3175-3180. PubMed ID: 28270605
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous Enrichment of Plasma Extracellular Vesicles and Glycoproteome for Studying Disease Biomarkers.
Adav SS; Sze SK
Methods Mol Biol; 2017; 1619():193-201. PubMed ID: 28674887
[TBL] [Abstract][Full Text] [Related]
10. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
Smith JG; Gerszten RE
Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
[TBL] [Abstract][Full Text] [Related]
11. Mixed-mode ion exchange-based integrated proteomics technology for fast and deep plasma proteome profiling.
Xue L; Lin L; Zhou W; Chen W; Tang J; Sun X; Huang P; Tian R
J Chromatogr A; 2018 Aug; 1564():76-84. PubMed ID: 29935814
[TBL] [Abstract][Full Text] [Related]
12. Plasma-derived microparticles for biomarker discovery.
Smalley DM; Ley K
Clin Lab; 2008; 54(3-4):67-79. PubMed ID: 18630736
[TBL] [Abstract][Full Text] [Related]
13. Shotgun and Targeted Plasma Proteomics to Predict Prognosis of Non-Small Cell Lung Cancer.
Li QR; Liu YS; Zeng R
Methods Mol Biol; 2017; 1619():385-394. PubMed ID: 28674898
[TBL] [Abstract][Full Text] [Related]
14. Protocol for Plasma Extracellular Vesicle and Particle Isolation and Mass Spectrometry-Based Proteomic Identification.
Kenari AN; Bojmar L; Heissel S; Molina H; Lyden D; Hoshino A
Methods Mol Biol; 2023; 2628():291-300. PubMed ID: 36781793
[TBL] [Abstract][Full Text] [Related]
15. Absolute Quantification of Middle- to High-Abundant Plasma Proteins via Targeted Proteomics.
Dittrich J; Ceglarek U
Methods Mol Biol; 2017; 1619():417-430. PubMed ID: 28674901
[TBL] [Abstract][Full Text] [Related]
16. Plasma Proteome Profiling to Assess Human Health and Disease.
Geyer PE; Kulak NA; Pichler G; Holdt LM; Teupser D; Mann M
Cell Syst; 2016 Mar; 2(3):185-95. PubMed ID: 27135364
[TBL] [Abstract][Full Text] [Related]
17. Mass Spectrometry-Based Serum Proteomics for Biomarker Discovery and Validation.
Bhosale SD; Moulder R; Kouvonen P; Lahesmaa R; Goodlett DR
Methods Mol Biol; 2017; 1619():451-466. PubMed ID: 28674903
[TBL] [Abstract][Full Text] [Related]
18. Qualification and Verification of Protein Biomarker Candidates.
Zhao Y; Brasier AR
Adv Exp Med Biol; 2016; 919():493-514. PubMed ID: 27975232
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.
Aqrawi LA; Galtung HK; Vestad B; Øvstebø R; Thiede B; Rusthen S; Young A; Guerreiro EM; Utheim TP; Chen X; Utheim ØA; Palm Ø; Jensen JL
Arthritis Res Ther; 2017 Jan; 19(1):14. PubMed ID: 28122643
[TBL] [Abstract][Full Text] [Related]
20. Targeted Approach for Proteomic Analysis of a Hidden Membrane Protein.
Martins-Marques T; Anjo SI; Ribeiro-Rodrigues T; Manadas B; Girao H
Methods Mol Biol; 2017; 1619():151-172. PubMed ID: 28674884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
